These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 21512392

  • 1. Chronic obstructive pulmonary disease megatrials: taking the results into office practice.
    Stoloff SW.
    Am J Med Sci; 2011 Aug; 342(2):160-7. PubMed ID: 21512392
    [Abstract] [Full Text] [Related]

  • 2. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
    Niewoehner DE.
    COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
    [Abstract] [Full Text] [Related]

  • 3. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 4. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED, van Dyk M, Sagriotis A.
    Pulm Pharmacol Ther; 2008 Oct; 21(1):20-5. PubMed ID: 17118684
    [Abstract] [Full Text] [Related]

  • 5. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [Abstract] [Full Text] [Related]

  • 6. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen A.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):105; author reply 106-7. PubMed ID: 18565963
    [No Abstract] [Full Text] [Related]

  • 7. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar 01; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 8. Do we need three players in COPD treatment?
    Maestrelli P, Mason P, Costa F, Paggiaro P.
    Respiration; 2013 Mar 01; 86(4):275-6. PubMed ID: 23988429
    [No Abstract] [Full Text] [Related]

  • 9. Outcomes and costs associated with initial maintenance therapy with fluticasone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPD.
    Dalal AA, Candrilli SD, Davis KL.
    Manag Care; 2011 Aug 01; 20(8):46-50, 53-5. PubMed ID: 21887993
    [Abstract] [Full Text] [Related]

  • 10. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.
    Postgrad Med; 2010 Sep 01; 122(5):150-64. PubMed ID: 20861599
    [Abstract] [Full Text] [Related]

  • 11. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
    Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE.
    Respir Med; 2012 Jan 01; 106(1):91-101. PubMed ID: 22040533
    [Abstract] [Full Text] [Related]

  • 12. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):332-8. PubMed ID: 18511702
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
    Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.
    Chest; 2007 Dec 15; 132(6):1756-63. PubMed ID: 17951625
    [Abstract] [Full Text] [Related]

  • 14. Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.
    Miravitlles M, Anzueto A.
    Int J Chron Obstruct Pulmon Dis; 2009 Dec 15; 4():185-201. PubMed ID: 19516917
    [Abstract] [Full Text] [Related]

  • 15. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 15; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 16. External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
    Hoogendoorn M, Feenstra TL, Asukai Y, Briggs AH, Hansen RN, Leidl R, Risebrough N, Samyshkin Y, Wacker M, Rutten-van Mölken MP.
    Value Health; 2017 Mar 15; 20(3):397-403. PubMed ID: 28292484
    [Abstract] [Full Text] [Related]

  • 17. Treatment step down should be avoided at entry in COPD therapeutic trials.
    Marchand E.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):105-6; author reply 106-7. PubMed ID: 18565962
    [No Abstract] [Full Text] [Related]

  • 18. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.
    Ann Intern Med; 2007 Apr 17; 146(8):I12. PubMed ID: 17310044
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
    Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group.
    Respir Med; 2012 Mar 17; 106(3):382-9. PubMed ID: 21975275
    [Abstract] [Full Text] [Related]

  • 20. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM, POET-COPD Investigators.
    N Engl J Med; 2011 Mar 24; 364(12):1093-1103. PubMed ID: 21428765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.